2022-10 – Q3 2022 Reporting

  • Transition to the new Australian based CRO was finalized during Q3.
  • Australian ethical committee has approved increasing dosing period from 3 to 6 months.
  • Reactivation of Australian centers by the new CRO.
  • Centers in New Zealand are being added to the Australian centers.

Read more here